Symposia
During ECR 2023 we sponsored two Symposia with remarkable speakers.
Stay tuned, as we will make available soon the recordings of each of the Satelite Symposia.
Learn What’s New in Ultrasound Liver Analysis and in CT & MRI Screening and Follow-up!
Stay tuned, as we will make available soon the recordings of each of the Satelite Symposia.
Learn What’s New in Ultrasound Liver Analysis and in CT & MRI Screening and Follow-up!
Satellite Symposium (Ultrasound)
Date: Wednesday, March 1Time: 11:30-12:30
Location: Room N
Title: Ultrasound Liver Analysis: What’s New
Subtitle: From Early Detection and Diagnosis to Treatment
The prevalence of diffuse liver disease is increasing and is now a worldwide problem. In addition to alcohol abuse or chronic hepatitis, other causes are emerging such as metabolic syndrome leading to a higher prevalence of fatty liver or liver-related diseases. The wide variety of these causes and their impact on the liver require the combination of conventional ultrasound with new advanced diagnostic techniques to provide adequate staging of the patient. This symposium will review the use and diagnostic performance of these techniques such as elastography for the quantification of liver stiffness, fibrosis using Shear wave technology (SWE), the new tissue attenuation parameter (ATI) for the quantification of steatosis or the inflammatory dispersion of liver tissue (SWD).
5 min | Introduction - Prof. Valérie Vilgrain, Paris, France (moderator)
20 min | Liver Shear Wave Elastography: SRU Consensus/Attenuation Imaging: Toward Standardization of Measurements - Dr. Giovanna Ferraioli, Pavia, Italy
20 min | Are We Ready for Global Ultrasound Analysis for Chronic Liver Diseases? - Dr. Marco Dioguardi Burgio, Paris, France
15 min | Summary and Perspective - Prof. Valérie Vilgrain , Paris, France (moderator)
Satellite Lunch Symposium (CT/MRI)
Date: Friday, March 3Time: 12:30-13:30
Location: Room M
Title: CT & MRI Screening and Follow-up: What’s New
Subtitle: Clinical Experience with New AI Technologies
The European Union Council recently adopted a new approach to cancer screening, following the Commission's proposal to boost cancer prevention through early diagnosis. This is an important step in improving early detection throughout the EU, which is a fundamental goal of Europe's Beating Cancer Plan. The new strategy calls for gradually expanding population-based screening programs to include lung and prostate. *
This Symposium will concentrate on CT screening for lung cancer and MRI screening for prostate cancer.
- Learn about Canon Medical's new CT scanner and why it is ideal for lung cancer screening.
- Understand the evolution of AI in prostate MRI and its impact on clinical practice. How might AI help with prostate cancer screening by employing MRI as a supporting imaging modality?
20 min | Harnessing the Power of Automation in CT to Serve Screening Purposes - Dr. Russell Bull, Bournemouth, UK
20 min | AI in prostate MRI: current applications and perspectives (MRI)- Dr. Pierre Leyendecker, Strasbourg, France
15 min | Summary and perspective - Prof. Stefan M. Niehues, Berlin, Germany
* source: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_5562
More Information on our Satellite Symposium (Ultrasound)
Moderator:
Prof. Valérie Vilgrain, MD, PhD
Radiologist
Head of Radiology Departement
Beaujon Hospital - APHP
Paris, France
Head of Radiology at Beaujon University Hospital, Clichy, Université Paris 7, France. Dr. Vilgrain is currently full professor of radiology at the University of Paris 7 Denis Diderot, France. She is a member of several national and international societies, inter alia RSNA (Radiological Society of North America), VS (European Society of Radiology), ESGAR (European Society of Gastro and Abdominal Radiology) and SFR (French Radiological Society).
Radiologist
Head of Radiology Departement
Beaujon Hospital - APHP
Paris, France
Head of Radiology at Beaujon University Hospital, Clichy, Université Paris 7, France. Dr. Vilgrain is currently full professor of radiology at the University of Paris 7 Denis Diderot, France. She is a member of several national and international societies, inter alia RSNA (Radiological Society of North America), VS (European Society of Radiology), ESGAR (European Society of Gastro and Abdominal Radiology) and SFR (French Radiological Society).
Speaker:
Dr. Giovanna Ferraioli, MD
Researcher
Reference Doctor
Department of Infectious and Tropical Diseases Foundation IRCCS
Policlinico San Matteo, University of Pavia
Pavia, Italy
Reference Doctor, Ultrasound Unit, Department of Infectious and Tropical Diseases Foundation IRCCS. Dr. Ferraioli is a researcher at Fondazione IRCCS Policlinico San Matteo, Medical School, University of Pavia, (Italy). Her research interests include elastography in diffuse liver disease, non-invasive assessment of liver steatosis, ultrasound contrast agents, and Doppler in portal hypertension. She is the coordinator of the Ultrasound School at Fondazione IRCCS San Matteo Hospital Foundation, Medical School of the University of Pavia (Italy), and co-director of the EFSUMB Ultrasound Learning Center (ULC) at the same Institution.
Presentation title: Liver Shear Wave Elastography: SRU Consensus/Attenuation Imaging: Toward Standardization of Measurements
SRU consensus underscores that a correct protocol for liver stiffness measurement with the acoustic radiation force impulse (ARFI)-based techniques must be followed, taking into consideration several confounding factors. It has also highlighted that the overlap of liver stiffness values between histologic stages of liver fibrosis is as large if not larger than the difference between vendor’s techniques. Therefore, a vendor-independent “rule of 4” is suggested.
A standardization of the measurement of liver fat content with attenuation imaging is needed because there are several factors that may affect the readings.
Researcher
Reference Doctor
Department of Infectious and Tropical Diseases Foundation IRCCS
Policlinico San Matteo, University of Pavia
Pavia, Italy
Reference Doctor, Ultrasound Unit, Department of Infectious and Tropical Diseases Foundation IRCCS. Dr. Ferraioli is a researcher at Fondazione IRCCS Policlinico San Matteo, Medical School, University of Pavia, (Italy). Her research interests include elastography in diffuse liver disease, non-invasive assessment of liver steatosis, ultrasound contrast agents, and Doppler in portal hypertension. She is the coordinator of the Ultrasound School at Fondazione IRCCS San Matteo Hospital Foundation, Medical School of the University of Pavia (Italy), and co-director of the EFSUMB Ultrasound Learning Center (ULC) at the same Institution.
Presentation title: Liver Shear Wave Elastography: SRU Consensus/Attenuation Imaging: Toward Standardization of Measurements
SRU consensus underscores that a correct protocol for liver stiffness measurement with the acoustic radiation force impulse (ARFI)-based techniques must be followed, taking into consideration several confounding factors. It has also highlighted that the overlap of liver stiffness values between histologic stages of liver fibrosis is as large if not larger than the difference between vendor’s techniques. Therefore, a vendor-independent “rule of 4” is suggested.
A standardization of the measurement of liver fat content with attenuation imaging is needed because there are several factors that may affect the readings.
Speaker:
Dr. Marco Dioguardi Burgio, MD
Radiologist
Beaujon Hospital
Paris, France
Marco Dioguardi Burgio is an academic researcher from University of Paris. The author has contributed to research in topic(s): Tare weight & Fatty liver. The author has an hindex of 4, co-authored 16 publication(s) receiving 45 citation(s). Previous affiliations of Marco Dioguardi Burgio include French Institute of Health and Medical Research & Beaujon Hospital.
Presentation title: Are We Ready for Global Ultrasound Analysis for Chronic Liver Diseases?
Evaluation of liver inflammation is a key element in the assessment of patients with chronic liver disease. Indeed, its presence may favor the development of liver fibrosis. Currently, there are no validated non-invasive methods to estimate hepatic inflammation.
The dispersion properties of shear waves can be used as method for measuring the viscosity in the liver, which is considered to be linked to inflammation.
Some recent data suggest that a US approach evaluating the dispersion slope, calculated from 2D-SWE, can be used as a non-invasive biomarker of hepatic inflammation.
This session will discuss the basic principles of the dispersion slope assessment, the actual applications as well as the possible future directions.
Radiologist
Beaujon Hospital
Paris, France
Marco Dioguardi Burgio is an academic researcher from University of Paris. The author has contributed to research in topic(s): Tare weight & Fatty liver. The author has an hindex of 4, co-authored 16 publication(s) receiving 45 citation(s). Previous affiliations of Marco Dioguardi Burgio include French Institute of Health and Medical Research & Beaujon Hospital.
Presentation title: Are We Ready for Global Ultrasound Analysis for Chronic Liver Diseases?
Evaluation of liver inflammation is a key element in the assessment of patients with chronic liver disease. Indeed, its presence may favor the development of liver fibrosis. Currently, there are no validated non-invasive methods to estimate hepatic inflammation.
The dispersion properties of shear waves can be used as method for measuring the viscosity in the liver, which is considered to be linked to inflammation.
Some recent data suggest that a US approach evaluating the dispersion slope, calculated from 2D-SWE, can be used as a non-invasive biomarker of hepatic inflammation.
This session will discuss the basic principles of the dispersion slope assessment, the actual applications as well as the possible future directions.
More Information on our Satellite Lunch Symposium (CT/MRI)
Moderator: Prof. Stefan Markus Niehues,
MD, MHBA
Radiologist, Deputy Director, and Senior Physician
Deputy Director, and Senior Physician
Charité University Medical Center
Berlin, Germany
Stefan M. Niehues currently works at the Institute of Radiology, Charité Universitätsmedizin Berlin, and does research in Radiology. The focus of Prof. Niehues as Deputy Clinic Director is on the management, organization, and continuing development of the field of radiology at the Benjamin Franklin campus of the Charité-Universitätsmedizin Berlin. In addition, he is responsible for Computed Tomography and interventions, teaching, cardiovascular imaging, and oncological studies.
Radiologist, Deputy Director, and Senior Physician
Deputy Director, and Senior Physician
Charité University Medical Center
Berlin, Germany
Stefan M. Niehues currently works at the Institute of Radiology, Charité Universitätsmedizin Berlin, and does research in Radiology. The focus of Prof. Niehues as Deputy Clinic Director is on the management, organization, and continuing development of the field of radiology at the Benjamin Franklin campus of the Charité-Universitätsmedizin Berlin. In addition, he is responsible for Computed Tomography and interventions, teaching, cardiovascular imaging, and oncological studies.
Speaker: Dr. Russell Bull,
BSc, MBBChir, MRCP, FRCR, FSCCT
Radiologist
Consultant Radiologist at the Radiology Department
Royal Bournemouth Hospital
Bournemouth, UK
Dr. Russell Bull has 15 years of radiology experience at consultant level and 11 years of experience in cardiac CT and cardiac MRI scanning. He is Level 3 accredited in cardiac CT by SCCT and BSCI.
Russell has been involved in the development of Canon PUREViSION optics combined with ultra-low, dose-efficient detector for CT in conjunction with Canon Medical. This allows patients to be scanned more safely using lower doses of radiation and IV contrast.
He currently supervises and reports over 500 cardiac CT and 500 cardiac MRI examinations per year.
Presentation title: Harnessing the Power of Automation in CT to Serve Screening Purposes
Although CT of the thorax is a well-established technology, it has limited use in particular populations, such as younger patients, due to radiation dosage issues. Because of the use of silver filtration, CT may be conducted at dosages comparable to plain film while delivering far more diagnostic information. There will be demonstrations of image quality and radiation exposures utilizing a new CT scanner, the Aquilion Serve. In addition, the system’s latest technologies that harness the power of automation in the workflow will be discussed.
Radiologist
Consultant Radiologist at the Radiology Department
Royal Bournemouth Hospital
Bournemouth, UK
Dr. Russell Bull has 15 years of radiology experience at consultant level and 11 years of experience in cardiac CT and cardiac MRI scanning. He is Level 3 accredited in cardiac CT by SCCT and BSCI.
Russell has been involved in the development of Canon PUREViSION optics combined with ultra-low, dose-efficient detector for CT in conjunction with Canon Medical. This allows patients to be scanned more safely using lower doses of radiation and IV contrast.
He currently supervises and reports over 500 cardiac CT and 500 cardiac MRI examinations per year.
Presentation title: Harnessing the Power of Automation in CT to Serve Screening Purposes
Although CT of the thorax is a well-established technology, it has limited use in particular populations, such as younger patients, due to radiation dosage issues. Because of the use of silver filtration, CT may be conducted at dosages comparable to plain film while delivering far more diagnostic information. There will be demonstrations of image quality and radiation exposures utilizing a new CT scanner, the Aquilion Serve. In addition, the system’s latest technologies that harness the power of automation in the workflow will be discussed.
Speaker: Dr. Pierre Leyendecker,
MD, MSc
Radiologist
Medical Imaging Group - MIM, Sainte Anne Clinic
Strasbourg, France
Dr. Pierre Leyendecker is a radiologist specialized in the field of the urinary tract and oncology. His activity is mainly settled in the Saint-Anne Clinic which is a well know oncology center in Strasbourg, France. Thanks to his position of attached practitioner in the Nouvel Hôpital Civil, University Hospital Strasbourg, he is involved in training of medical students in radiology. He is a member of the French association of Urology (CLAFU) and participates in research partnerships with urologists.
Presentation title: AI in Prostate MRI: Current Applications and Perspectives
Magnetic Resonance Imaging (MRI) offers reliable visualization of potentially significant prostate cancers and thus has shown advantages as a means by which to better select patients for biopsy and facilitate direct targeting of lesions during biopsy. Major technical improvements in multiparametric prostate MRI with the standard approach to interpretation using the prostate imaging reporting and data system version 2.1 (PI-RADS v2.1) have rapidly expanded the role of MRI in prostate cancer management in many clinical contexts, both prior to and following diagnosis. This presentation will deal with the development of AI in prostate MRI and its contribution in clinical routine.
Radiologist
Medical Imaging Group - MIM, Sainte Anne Clinic
Strasbourg, France
Dr. Pierre Leyendecker is a radiologist specialized in the field of the urinary tract and oncology. His activity is mainly settled in the Saint-Anne Clinic which is a well know oncology center in Strasbourg, France. Thanks to his position of attached practitioner in the Nouvel Hôpital Civil, University Hospital Strasbourg, he is involved in training of medical students in radiology. He is a member of the French association of Urology (CLAFU) and participates in research partnerships with urologists.
Presentation title: AI in Prostate MRI: Current Applications and Perspectives
Magnetic Resonance Imaging (MRI) offers reliable visualization of potentially significant prostate cancers and thus has shown advantages as a means by which to better select patients for biopsy and facilitate direct targeting of lesions during biopsy. Major technical improvements in multiparametric prostate MRI with the standard approach to interpretation using the prostate imaging reporting and data system version 2.1 (PI-RADS v2.1) have rapidly expanded the role of MRI in prostate cancer management in many clinical contexts, both prior to and following diagnosis. This presentation will deal with the development of AI in prostate MRI and its contribution in clinical routine.
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems global webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.
